News

AbbVie targets psychedelic-based depression drug market with $1.2 billion deal

AbbVie will buy an experimental depression drug from partner Gilgamesh Pharmaceuticals for up to $1.2 billion, the companies ...

Metformin: Science finds new benefits from an old drug

A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...

Indole chemistry advance could accelerate drug development with precise targeting

Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core ...

FDA approves use of animal drugs to treat New World Screwworm

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...

F.D.A. Targets Mousse and Foam Sunscreens

The agency issued warnings to companies that make foam and whipped sunscreens, but that doesn’t necessarily mean the products ...

People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

FDA’s new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

US FDA declines to approve PTC Therapeutics' oral drug for rare genetic disorder

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

FDA approves Ionis’ hereditary angioedema drug

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.